Skip to main content
OpenTrials
Completed

NCT Number: NCT04896151

Assessing the Utility of MMPI-2-RF-EX in Detecting Simulated Underreporting of Current Suicide Risk in Military Veterans

The aim of the current project are is examine the incremental predictive utility of the MMPI-2-RF-EX validity scales in detecting simulated underreporting of suicide risk on the MMPI-2-RF-EX and other self-report measures of suicide risk in 150 military Veterans experiencing past-month death or suicidal ideation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Ohio State University

Columbus, Ohio, 43214, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • US military veteran
  • death or suicidal ideation/suicide attempt within the past month

Exclusion criteria

  • non-Veteran status
  • acute intoxication or active psychosis precluding provision of informed consent
  • an inability to communicate and comprehend English
  • residence outside the United States
  • lack of past-month death/suicide ideation or attempt
  • younger than 18 years of age

Treatment and study plan

Minnesota Multiphasic Personality Inventory -2- Restructured Form - Experimental

Diagnostic Test

The MMPI-2-RF-EX is a broadband, self-report measure of personality and psychopathology was developed for research purposes in order to develop the MMPI-3 (Ben-Porath & Tellegen, 2020), which is comprised of a subset of MMPI-2-RF-EX items.

Other names: MMPI-2-RF-EX

Primary outcomes

  1. MMPI-2-RF-EX Suicidal/Death Ideation scale

    Time frame: Baseline

    The MMPI-2-RF-EX Suicidal/Death Ideation scale is a self-report measure of current suicide risk contained within the instrument. T scores range from 45 to 100, with higher scores indicative of greater suicide risk.

  2. Beck Scale for Suicide Ideation (BSS)

    Time frame: Baseline

    The BSS is a 21-item measure of past-week suicide ideation and desire for death. Responses to items are scored on a 3-point Likert scale (range of 0- 2). Scores range from 0 to 42, with higher scores indicating greater suicide risk.

Secondary outcomes

  1. Suicide Cognitions Scale (SCS)

    Time frame: Baseline

    The SCS is an 18-item survey measuring suicide-related thoughts and beliefs, unclouding hopelessness, perceived burdensomeness, entrapment, and unbearability. Respondents rate their agreement with each statement on a 5-point Likert scale. Scores range from 18-90, with higher scores indicating more severe suicide risk.

Other outcomes

  1. Short Grit Scale

    Time frame: Baseline

    The Short Grit Scale is an 8-item measure of trait-level perseverance and passion for long-term goals. Possible scores range from 5 to 40, with higher scores indicting higher levels of grit.

  2. MMPI Posttest Inquiry (PTI)

    Time frame: Baseline

    The PTI assesses participants' compliance with condition-specific instructions for completing the MMPI and was adapted for the proposed research

  3. PTSD Checklist for DSM-5 (PCL-5) PTSD Checklist for DSM-5

    Time frame: Baseline

    The PCL-5 is a self-report measure assessing the severity of 20 PTSD symptoms. Scores range from 0 to 80, with higher scores indicating greater PTSD symptom severity.

Sponsors and collaborators

Lead sponsor

Ohio State University

Other

Collaborators

  • Rutgers University
  • University of Minnesota

Registry information

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
May 21, 2021
Registry last updated
Oct 5, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.